BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu YC, Mao YM, Chen CW, Chen JJ, Chen J, Cong WM, Ding Y, Duan ZP, Fu QC, Guo XY, Hu P, Hu XQ, Jia JD, Lai RT, Li DL, Liu YX, Lu LG, Ma SW, Ma X, Nan YM, Ren H, Shen T, Wang H, Wang JY, Wang TL, Wang XJ, Wei L, Xie Q, Xie W, Yang CQ, Yang DL, Yu YY, Zeng MD, Zhang L, Zhao XY, Zhuang H;  Drug-induced Liver Injury (DILI) Study Group;  Chinese Society of Hepatology (CSH);  Chinese Medical Association (CMA). CSH guidelines for the diagnosis and treatment of drug-induced liver injury. Hepatol Int. 2017;11:221-241. [PMID: 28405790 DOI: 10.1007/s12072-017-9793-2] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramos-Tovar E, Muriel P. Free radicals, antioxidants, nuclear factor-E2-related factor-2 and liver damage. J Appl Toxicol 2020;40:151-68. [PMID: 31389060 DOI: 10.1002/jat.3880] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 9.5] [Reference Citation Analysis]
2 Xu Z, Kang Q, Yu Z, Tian L, Zhang J, Wang T. Research on the Species Difference of the Hepatotoxicity of Medicine Based on Transcriptome. Front Pharmacol 2021;12:647084. [PMID: 33995060 DOI: 10.3389/fphar.2021.647084] [Reference Citation Analysis]
3 Tian QJ, Zhao XY, Wang Y, Wee A, Soon GST, Gouw ASH, Li M, Yang RY, Wang L, Wang QY, Duan WJ, Wang Y, Wang XM, Kong YY, Ou XJ, You H, Jia JD. Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury. Mod Pathol 2019;32:1795-805. [PMID: 31300804 DOI: 10.1038/s41379-019-0314-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Almogairen SM. Abatacept induced granulomatous hepatitis with a sarcoidosis- like reaction: a blinded trial in mice. BMC Pharmacol Toxicol 2019;20:26. [PMID: 31064410 DOI: 10.1186/s40360-019-0303-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sridharan K, Daylami AA, Ajjawi R, Ajooz HAMA. Drug-Induced Liver Injury in Critically Ill Children Taking Antiepileptic Drugs: A Retrospective Study. Curr Ther Res Clin Exp 2020;92:100580. [PMID: 32280391 DOI: 10.1016/j.curtheres.2020.100580] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Bessone F. Overview on drug-induced liver injury in Brazil. WJGPT 2021;12:100-2. [DOI: 10.4292/wjgpt.v12.i5.100] [Reference Citation Analysis]
7 Xie Z, Chen E, Ouyang X, Xu X, Ma S, Ji F, Wu D, Zhang S, Zhao Y, Li L. Metabolomics and Cytokine Analysis for Identification of Severe Drug-Induced Liver Injury. J Proteome Res 2019;18:2514-24. [PMID: 31002254 DOI: 10.1021/acs.jproteome.9b00047] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
8 Tan YL, Tey SM, Ho HK. Moderate Hypothermia Effectively Alleviates Acetaminophen-Induced Liver Injury With Prolonged Action Beyond Cooling. Dose Response 2020;18:1559325820970846. [PMID: 33239997 DOI: 10.1177/1559325820970846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhu J, Liu W, Zhang M, Lu L, Pan H, He X, Wang N, Yang M, Yi H, Tang S. A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population. J Clin Pharm Ther 2021. [PMID: 34046917 DOI: 10.1111/jcpt.13452] [Reference Citation Analysis]
10 Zhu W, Wang L, Zhao X, Wang T, Shi X, Ou X, Wang Y, Wang X, Duan W, Wang Q, Jia J, Ma H. Prolonged interval of total bilirubin decline is an early independent predictive factor of chronic persistent drug‐induced liver injury. Hepatol Res 2020;50:224-32. [DOI: 10.1111/hepr.13435] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Liu Y, Zhang J, Yin Z, Zhu X, Xue L, Cao B. Compromise or not? A case report of successful treatment of pembrolizumab-induced hepatitis in a patient with non-small cell lung cancer with low-dose methylprednisolone and bicyclol. Thorac Cancer 2020;11:2023-30. [PMID: 32379397 DOI: 10.1111/1759-7714.13463] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Luo Y, Gao F, Chang R, Zhang X, Zhong J, Wen J, Wu J, Zhou T. Metabolomics based comprehensive investigation of Gardeniae Fructus induced hepatotoxicity. Food Chem Toxicol 2021;153:112250. [PMID: 33964367 DOI: 10.1016/j.fct.2021.112250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Teschke R, Zhu Y, Jing J. Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases. J Clin Transl Hepatol 2020;8:200-14. [PMID: 32832401 DOI: 10.14218/JCTH.2020.00009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
14 Luo Y, Zhang X, Zhang W, Yang Q, You W, Wen J, Zhou T. Compatibility with Semen Sojae Praeparatum attenuates hepatotoxicity of Gardeniae Fructus by regulating the microbiota, promoting butyrate production and activating antioxidant response. Phytomedicine 2021;90:153656. [PMID: 34332844 DOI: 10.1016/j.phymed.2021.153656] [Reference Citation Analysis]
15 Zhou J, Li Y, Liu X, Long Y, Chen J. LncRNA-Regulated Autophagy and its Potential Role in Drug-Induced Liver Injury. Ann Hepatol 2018;17:355-63. [PMID: 29735795 DOI: 10.5604/01.3001.0011.7381] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
16 Jin M, Yi X, Liao W, Chen Q, Yang W, Li Y, Li S, Gao Y, Peng Q, Zhou S. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing. Stem Cell Res Ther 2021;12:84. [PMID: 33494782 DOI: 10.1186/s13287-021-02152-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Lee H, Kang HY, Cho S, Park S, Kim AY, Jung SY, Seong BL, Lee YM. Causality Assessment Guidelines for Adverse Events Following Immunization with a Focus on Guillain-Barré Syndrome. Vaccines (Basel) 2020;8:E101. [PMID: 32102455 DOI: 10.3390/vaccines8010101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Alfarisi HAH, Ibrahim MB, Mohamed ZBH, Azahari N, Hamdan AHB, Che Mohamad CA. Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin. ScientificWorldJournal 2020;2020:4503253. [PMID: 33132768 DOI: 10.1155/2020/4503253] [Reference Citation Analysis]
19 Shen T, Liu Y, Shang J, Xie Q, Li J, Yan M, Xu J, Niu J, Liu J, Watkins PB, Aithal GP, Andrade RJ, Dou X, Yao L, Lv F, Wang Q, Li Y, Zhou X, Zhang Y, Zong P, Wan B, Zou Z, Yang D, Nie Y, Li D, Wang Y, Han X, Zhuang H, Mao Y, Chen C. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology. 2019;156:2230-2241.e11. [PMID: 30742832 DOI: 10.1053/j.gastro.2019.02.002] [Cited by in Crossref: 124] [Cited by in F6Publishing: 100] [Article Influence: 62.0] [Reference Citation Analysis]
20 Chen Y, Ye P, Ren C, Ren P, Ma Z, Zhang L, Zhou W, Jiang C. Pharmacoeconomics of three Therapeutic Schemes for Anti-tuberculosis Therapy Induced Liver Injury in China. Open Med (Wars) 2018;13:53-63. [PMID: 29607414 DOI: 10.1515/med-2018-0010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Wang Q, Huang A, Wang JB, Zou Z. Chronic Drug-Induced Liver Injury: Updates and Future Challenges. Front Pharmacol 2021;12:627133. [PMID: 33762948 DOI: 10.3389/fphar.2021.627133] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Abramavicius S, Velickiene D, Kadusevicius E. Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report. Medicine (Baltimore) 2017;96:e8159. [PMID: 28953662 DOI: 10.1097/MD.0000000000008159] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Jing J, Wang RL, Zhao XY, Zhu Y, Niu M, Wang LF, Song XA, He TT, Sun YQ, Xu WT, Yu SM, Wang LP, Guo YM, Bai ZF, Xiao XH, Wang JB. Association between the concurrence of pre-existing chronic liver disease and worse prognosis in patients with an herb- Polygonum multiflorum thunb. induced liver injury: a case-control study from a specialised liver disease center in China. BMJ Open. 2019;9:e023567. [PMID: 30782709 DOI: 10.1136/bmjopen-2018-023567] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
24 Tian Q, Yang R, Wang Y, Liu J, Wee A, Saxena R, Wang L, Li M, Liu L, Shan S, Kong Y, Ma H, Ou X, You H, Zhao X, Jia J. A High Serum Level of Taurocholic Acid Is Correlated With the Severity and Resolution of Drug-induced Liver Injury. Clin Gastroenterol Hepatol 2021;19:1009-1019.e11. [PMID: 32634627 DOI: 10.1016/j.cgh.2020.06.067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Zhang C, Wang N, Xu Y, Tan HY, Li S, Feng Y. Molecular Mechanisms Involved in Oxidative Stress-Associated Liver Injury Induced by Chinese Herbal Medicine: An Experimental Evidence-Based Literature Review and Network Pharmacology Study. Int J Mol Sci 2018;19:E2745. [PMID: 30217028 DOI: 10.3390/ijms19092745] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
26 Chen Y, Wang C, Yang H, Huang P, Shi J, Tong Y, Jiang J, Zhang X, Chen W, Xuan Z. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China. Biomed Res Int 2021;2021:8894498. [PMID: 33954202 DOI: 10.1155/2021/8894498] [Reference Citation Analysis]
27 Zhang Y, Wang D, Shen D, Luo Y, Che YQ. Identification of exosomal miRNAs associated with the anthracycline-induced liver injury in postoperative breast cancer patients by small RNA sequencing. PeerJ 2020;8:e9021. [PMID: 32355577 DOI: 10.7717/peerj.9021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
28 Chen K, Guo N, Zhang R, Wei C, Guo R. CYP2E1 and miRNA‐378a‐3p contribute to acetaminophen‐ or tripterygium glycosides‐induced hepatotoxicity. Basic Clin Pharmacol Toxicol 2020;126:153-65. [DOI: 10.1111/bcpt.13313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Li X, Xu H, Gao P. Red Blood Cell Distribution Width-to-Platelet Ratio and Other Laboratory Indices Associated with Severity of Histological Hepatic Fibrosis in Patients with Autoimmune Hepatitis: A Retrospective Study at a Single Center. Med Sci Monit 2020;26:e927946. [PMID: 33180750 DOI: 10.12659/MSM.927946] [Reference Citation Analysis]
30 Teschke R. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.Expert Opin Drug Metab Toxicol. 2018;14:1169-1187. [PMID: 30354694 DOI: 10.1080/17425255.2018.1539077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
31 Wu DD, Wang DY, Li HM, Guo JC, Duan SF, Ji XY. Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease. Oxid Med Cell Longev 2019;2019:3831713. [PMID: 30805080 DOI: 10.1155/2019/3831713] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
32 Kong X, Guo D, Liu S, Zhu Y, Yu C. Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control study. Br J Clin Pharmacol 2021. [PMID: 33948989 DOI: 10.1111/bcp.14847] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Hernandez N, Pontet Y, Bessone F. Translating new knowledge on drug-induced liver injury into clinical practice. Frontline Gastroenterol 2020;11:303-10. [PMID: 32587673 DOI: 10.1136/flgastro-2018-101120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yan H, Du J, Chen X, Yang B, He Q, Yang X, Luo P. ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol 2019;383:114768. [PMID: 31639374 DOI: 10.1016/j.taap.2019.114768] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
35 Tao B, Yang M, Chen H, Pan H, Liu W, Yi H, Tang S. Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population. J Clin Pharm Ther 2020;45:638-45. [PMID: 32259340 DOI: 10.1111/jcpt.13139] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
36 Zhang H, Wu J, Zhang Z, Qian H, Wang Y, Yang M, Cheng Y, Tang S. Association of atorvastatin with the risk of hepatotoxicity: a pilot prescription sequence symmetry analysis. Ther Clin Risk Manag 2019;15:803-10. [PMID: 31417267 DOI: 10.2147/TCRM.S204860] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Jing J, Teschke R. Traditional Chinese Medicine and Herb-induced Liver Injury: Comparison with Drug-induced Liver Injury. J Clin Transl Hepatol 2018;6:57-68. [PMID: 29577033 DOI: 10.14218/JCTH.2017.00033] [Cited by in Crossref: 32] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
38 Hu T, Shi C, Liu L, Li P, Sun Y, An Z. A single-injection targeted metabolomics profiling method for determination of biomarkers to reflect tripterygium glycosides efficacy and toxicity. Toxicol Appl Pharmacol 2020;389:114880. [PMID: 31945383 DOI: 10.1016/j.taap.2020.114880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
39 Kuznietsova H, Lynchak O, Dziubenko N, Herheliuk T, Prylutskyy Y, Rybalchenko V, Ritter U. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injury. Bioimpacts 2019;9:227-37. [PMID: 31799159 DOI: 10.15171/bi.2019.28] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
40 Alyammahi SK, Abdin SM, Alhamad DW, Elgendy SM, Altell AT, Omar HA. The dynamic association between COVID-19 and chronic disorders: An updated insight into prevalence, mechanisms and therapeutic modalities. Infect Genet Evol 2021;87:104647. [PMID: 33264669 DOI: 10.1016/j.meegid.2020.104647] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
41 Chinese Society of Clinical Oncology, Union for China Lymphoma Investigators;., Chinese Society of Clinical Oncology, Union for China Leukemia Investigators;., Chinese Society of Hematology, Chinese Medical Association;., Chinese Medical Doctor Association, Hematology Branch. [Consensus of Chinese experts on prevention and standardized treatment of drug-induced liver injury in patients with blood diseases (2021)]. Zhonghua Xue Ye Xue Za Zhi 2021;42:185-92. [PMID: 33910302 DOI: 10.3760/cma.j.issn.0253-2727.2021.03.002] [Reference Citation Analysis]
42 Real M, Barnhill MS, Higley C, Rosenberg J, Lewis JH. Drug-Induced Liver Injury: Highlights of the Recent Literature. Drug Saf 2019;42:365-87. [PMID: 30343418 DOI: 10.1007/s40264-018-0743-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
43 Shen T, Mao Y, Chen C. Reply. Gastroenterology 2019;157:1439-40. [PMID: 31513795 DOI: 10.1053/j.gastro.2019.08.047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Niu B, Lei X, Xu Q, Ju Y, Xu D, Mao L, Li J, Zheng Y, Sun N, Zhang X, Mao Y, Li X. Protecting mitochondria via inhibiting VDAC1 oligomerization alleviates ferroptosis in acetaminophen-induced acute liver injury. Cell Biol Toxicol 2021. [PMID: 34401974 DOI: 10.1007/s10565-021-09624-x] [Reference Citation Analysis]
45 Kolarić TO, Ninčević V, Smolić R, Smolić M, Wu GY. Mechanisms of Hepatic Cholestatic Drug Injury. J Clin Transl Hepatol 2019;7:86-92. [PMID: 30944824 DOI: 10.14218/JCTH.2018.00042] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
46 Li XX, Cheng YC, Zhai SD, Yao P, Zhan SY, Shi LW. Risk of Liver Injury Associated with Intravenous Lipid Emulsions: A Prescription Sequence Symmetry Analysis. Front Pharmacol 2021;12:589091. [PMID: 33732151 DOI: 10.3389/fphar.2021.589091] [Reference Citation Analysis]
47 Yan T, Huang J, Nisar MF, Wan C, Huang W. The Beneficial Roles of SIRT1 in Drug-Induced Liver Injury. Oxid Med Cell Longev 2019;2019:8506195. [PMID: 31354914 DOI: 10.1155/2019/8506195] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
48 Danan G, Teschke R. Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch? Drug Saf. 2018;41:735-743. [PMID: 29502198 DOI: 10.1007/s40264-018-0654-2] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 14.7] [Reference Citation Analysis]
49 Imam Z, Khasawneh M, Jomaa D, Iftikhar H, Sayedahmad Z. Drug Induced Liver Injury Attributed to a Curcumin Supplement. Case Rep Gastrointest Med. 2019;2019:6029403. [PMID: 31781418 DOI: 10.1155/2019/6029403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF. Natural compounds as potential adjuvants to cancer therapy: Preclinical evidence. Br J Pharmacol 2020;177:1409-23. [PMID: 31368509 DOI: 10.1111/bph.14816] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 27.0] [Reference Citation Analysis]
51 Ye H, Nelson LJ, Gómez Del Moral M, Martínez-Naves E, Cubero FJ. Dissecting the molecular pathophysiology of drug-induced liver injury. World J Gastroenterol 2018;24:1373-85. [PMID: 29632419 DOI: 10.3748/wjg.v24.i13.1373] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
52 Naiqiong W, Liansheng W, Zhanying H, Yuanlin G, Chenggang Z, Ying G, Qian D, Dongchen L, Yanjun Z, Jianjun L. A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury. Med Sci Monit 2017;23:5760-6. [PMID: 29200411 DOI: 10.12659/msm.904090] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 3.8] [Reference Citation Analysis]
53 Teschke R, Eickhoff A, Wolff A, Xuan TD. Liver Injury from Herbs and “Dietary Supplements”: Highlights of a Literature Review from 2015 to 2017. Curr Pharmacol Rep 2018;4:120-31. [DOI: 10.1007/s40495-018-0124-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
54 Zhao Z, Bao L, Yu X, Zhu C, Xu J, Wang Y, Yin M, Li Y, Li W. Acute vanishing bile duct syndrome after therapy with cephalosporin, metronidazole, and clotrimazole: A case report. Medicine (Baltimore) 2017;96:e8009. [PMID: 28885366 DOI: 10.1097/MD.0000000000008009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
55 Li YC, Shen JD, Lu SF, Zhu LL, Wang BY, Bai M, Xu EP. Transcriptomic analysis reveals the mechanism of sulfasalazine-induced liver injury in mice. Toxicol Lett 2020;321:12-20. [PMID: 31830553 DOI: 10.1016/j.toxlet.2019.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
56 Zhu P, Li J, Fu X, Yu Z. Schisandra fruits for the management of drug-induced liver injury in China: A review. Phytomedicine 2019;59:152760. [PMID: 31004881 DOI: 10.1016/j.phymed.2018.11.020] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
57 Deng ML, Chen YJ, Yang ML, Liu YW, Chen H, Tang XQ, Yang XF. COVID-19 combined with liver injury: Current challenges and management. World J Clin Cases 2021;9:3487-97. [PMID: 34046449 DOI: 10.12998/wjcc.v9.i15.3487] [Reference Citation Analysis]
58 Teschke R, Eickhoff A, Brown AC, Neuman MG, Schulze J. Diagnostic Biomarkers in Liver Injury by Drugs, Herbs, and Alcohol: Tricky Dilemma after EMA Correctly and Officially Retracted Letter of Support. Int J Mol Sci 2019;21:E212. [PMID: 31892250 DOI: 10.3390/ijms21010212] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
59 Zhang C, Wu Y, Yuan S, Dou X, Sheng Q, Wang J, Tian W, Yao L, Ding Y. Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types. Dig Dis Sci 2020;65:3360-8. [PMID: 31907771 DOI: 10.1007/s10620-019-06030-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Tuohutaerbieke M, Li X, Yin Y, Chen W, Wu D, Mao Z, Mamuerjiang J, Mao Y, Shen T. The Characteristics, Prevalence, and Risk Factors of Drug-Induced Liver Injury Among Brucellosis Inpatients in Xinjiang, China. Front Pharmacol 2021;12:657805. [PMID: 34040524 DOI: 10.3389/fphar.2021.657805] [Reference Citation Analysis]
61 Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, Tian Q, Aggarwal R, Muljono DH, Omata M, Ooka Y, Han KH, Lee HW, Jafri W, Butt AS, Chong CH, Lim SG, Pwu RF, Chen DS. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5:167-228. [PMID: 31852635 DOI: 10.1016/s2468-1253(19)30342-5] [Cited by in Crossref: 58] [Cited by in F6Publishing: 21] [Article Influence: 29.0] [Reference Citation Analysis]
62 Wang L, Wang Y, Wee A, Soon G, Gouw ASH, Yang R, Tian Q, Liu L, Ma H, Zhao X. Clinicopathological features of Bu Gu Zhi-induced liver injury, a long-term follow-up cohort study.Liver Int. 2020;40:571-580. [PMID: 31758650 DOI: 10.1111/liv.14306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Li X, Wang L, Li D, Niu J, Gao P. Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. Med Sci Monit 2019;25:3344-53. [PMID: 31059494 DOI: 10.12659/MSM.916687] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
64 Philips CA, Paramaguru R, Augustine P, Rajesh S, Ahamed R, George T, Padsalgi G. A Single-Center Experience on Outcomes of Complementary and Alternative Medicine Use Among Patients With Cirrhosis. Hepatol Commun. 2019;3:1001-1012. [PMID: 31304453 DOI: 10.1002/hep4.1355] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
65 Xiao A, He HY, Chen Q, Ma SW. Drug-induced Liver Injury Due to Lepidium meyenii (Maca) Medicinal Liquor. Chin Med J (Engl) 2017;130:3005-6. [PMID: 29237937 DOI: 10.4103/0366-6999.220314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Abid A, Subhani F, Kayani F, Awan S, Abid S. Drug induced liver injury is associated with high mortality-A study from a tertiary care hospital in Pakistan. PLoS One 2020;15:e0231398. [PMID: 32276267 DOI: 10.1371/journal.pone.0231398] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
67 Melchart D, Hager S, Albrecht S, Dai J, Weidenhammer W, Teschke R. Herbal Traditional Chinese Medicine and suspected liver injury: A prospective study. World J Hepatol 2017;9:1141-57. [PMID: 29085558 DOI: 10.4254/wjh.v9.i29.1141] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
68 Wu H, Liu S, Luo H, Chen M. Progress in the Clinical Features and Pathogenesis of Abnormal Liver Enzymes in Coronavirus Disease 2019. J Clin Transl Hepatol 2021;9:239-46. [PMID: 34007806 DOI: 10.14218/JCTH.2020.00126] [Reference Citation Analysis]
69 Zhu Y, Niu M, Wang JB, Wang RL, Li JY, Ma YQ, Zhao YL, Zhang YF, He TT, Yu SM, Guo YM, Zhang F, Xiao XH, Schulze J. Predictors of poor outcomes in 488 patients with herb-induced liver injury. Turk J Gastroenterol. 2019;30:47-58. [PMID: 30289391 DOI: 10.5152/tjg.2018.17847] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
70 Meseguer ES, Elizalde MU, Borobia AM, Ramírez E. Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary Hospital. J Clin Med 2021;10:1153. [PMID: 33801850 DOI: 10.3390/jcm10061153] [Reference Citation Analysis]
71 Li H, Li M, Yan J, Gao L, Zhou L, Wang Y, Li Q, Wang J, Chen T, Wang T, Zheng J, Qiang W, Zhang Y, Shi Q. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy. Basic Clin Pharmacol Toxicol 2020;127:495-504. [PMID: 32639669 DOI: 10.1111/bcpt.13465] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
72 Devarbhavi H, Aithal G, Treeprasertsuk S, Takikawa H, Mao Y, Shasthry SM, Hamid S, Tan SS, Philips CA, George J, Jafri W, Sarin SK; Asia Pacific Association of Study of Liver. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines. Hepatol Int 2021;15:258-82. [PMID: 33641080 DOI: 10.1007/s12072-021-10144-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
73 Niu H, Sanabria-cabrera J, Alvarez-alvarez I, Robles-diaz M, Stankevičiūtė S, Aithal GP, Björnsson ES, Andrade RJ, Lucena MI. Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials. Pharmacological Research 2021;164:105404. [DOI: 10.1016/j.phrs.2020.105404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
74 Liu Y, Li P, Wang F, Liu L, Zhang Y, Liu Y, Shi R. Comparison of diagnostic accuracy of 3 diagnostic criteria combined with refined pathological scoring system for drug-induced liver injury. Medicine (Baltimore) 2020;99:e22259. [PMID: 33031266 DOI: 10.1097/MD.0000000000022259] [Reference Citation Analysis]
75 Zhu L, Zhang CY, Li DP, Chen HB, Ma J, Gao H, Ye Y, Wang JY, Fu PP, Lin G. Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Acta Pharmacol Sin 2021;42:1212-22. [PMID: 33154553 DOI: 10.1038/s41401-020-00553-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
76 Suh JI. Drug-induced liver injury. Yeungnam Univ J Med 2020;37:2-12. [PMID: 31661757 DOI: 10.12701/yujm.2019.00297] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
77 Teschke R. Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019. Front Pharmacol 2019;10:730. [PMID: 31396080 DOI: 10.3389/fphar.2019.00730] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
78 Hu PF, Xie WF. Corticosteroid therapy in drug-induced liver injury: Pros and cons. J Dig Dis. 2019;20:122-126. [PMID: 30582289 DOI: 10.1111/1751-2980.12697] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
79 Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Front Pharmacol. 2019;10:853. [PMID: 31417407 DOI: 10.3389/fphar.2019.00853] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
80 Huang X, Lee F, Teng Y, Lingam CB, Chen Z, Sun M, Song Z, Balachander GM, Leo HL, Guo Q, Shah I, Yu H. Sequential drug delivery for liver diseases. Adv Drug Deliv Rev 2019;149-150:72-84. [PMID: 31734169 DOI: 10.1016/j.addr.2019.11.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]